BlackRock discloses 1.64% stake in Mural Oncology
PositiveFinancial Markets

BlackRock has announced a 1.64% stake in Mural Oncology, signaling confidence in the company's potential in the biotech sector. This investment is significant as it highlights BlackRock's belief in Mural's innovative approaches to cancer treatment, which could lead to advancements in patient care and potentially lucrative returns for investors.
— Curated by the World Pulse Now AI Editorial System